EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of fructooligosaccharides on gut microbiota and microbial metabolites in gestational diabetes mellitus: An in vitro fermentation model study

Zhi Du, Yang Bi, Jiabin Li, Zhiwei Xu, Jieying Ding, Mengshan Huang, Meng Zhang, Daqing Ma, Hui Wang, Zhigang Liu, Jing Miao

Journal of Functional Foods · 2025-04 · 127 · 106740

DOI: 10.1016/j.jff.2025.106740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Functional Foods, 2025-04. Verfasst von Zhi Du und 10 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Zhejiang Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) is a prevalent metabolic disorder linked to gut microbiota dysbiosis. This study investigates the effects of fructooligosaccharides (FOS) on gut microbiota, microbial metabolites, and functional pathways using an in vitro fermentation model. Fecal samples from ten GDM patients were treated with FOS and analyzed via 16S rRNA sequencing and metabolomics. FOS supplementation enriched beneficial genera ( Bifidobacterium , Lactobacillus , Roseburia ) while reducing harmful taxa ( Escherichia-Shigella ). Metabolically, it increased acetate production and lowered harmful gases (ammonia, hydrogen sulfide). Predictive functional analysis revealed enhanced ribosome activity, amino acid biosynthesis, and quorum sensing, alongside reduced sugar metabolism and ATP-binding cassette transporters. These findings highlight FOS as a promising prebiotic for modulating gut microbiota, boosting short-chain fatty acid production, and improving metabolic health in GDM patients. This study offers novel insights into the mechanisms by which FOS influences gut microbial ecology and its therapeutic potential for GDM management. • FOS treatment enriches Bifidobacterium & Lactobacillus in feces from GDM. • FOS reduces Escherichia-Shigella and lowers toxic gases like ammonia and H₂S. • FOS elevates acetate production, promoting a healthier metabolic environment. • PICRUSt2 analysis shows enhanced amino acid biosynthesis and quorum sensing.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Zhejiang Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Du, Z., Bi, Y., Li, J., Xu, Z., Ding, J., Huang, M., Zhang, M., Ma, D., Wang, H., Liu, Z., & Miao, J. (2025). Impact of fructooligosaccharides on gut microbiota and microbial metabolites in gestational diabetes mellitus: An in vitro fermentation model study. Journal of Functional Foods, 127, 106740. https://doi.org/10.1016/j.jff.2025.106740

Vancouver

Du Z, Bi Y, Li J, Xu Z, Ding J, Huang M, et al. Impact of fructooligosaccharides on gut microbiota and microbial metabolites in gestational diabetes mellitus: An in vitro fermentation model study. Journal of Functional Foods. 2025;127:106740. doi:10.1016/j.jff.2025.106740

BibTeX
@article{Du2025,
  author = {Du, Zhi and Bi, Yang and Li, Jiabin and Xu, Zhiwei and Ding, Jieying and Huang, Mengshan and Zhang, Meng and Ma, Daqing and Wang, Hui and Liu, Zhigang and Miao, Jing},
  title = {Impact of fructooligosaccharides on gut microbiota and microbial metabolites in gestational diabetes mellitus: An in vitro fermentation model study},
  journal = {Journal of Functional Foods},
  year = {2025},
  volume = {127},
  pages = {106740},
  doi = {10.1016/j.jff.2025.106740}
}
Kostenlos starten →